The JAMA Network announces new names, new embargo schedules for specialty journals

December 20, 2012

Starting January 1, 2013 the Archives journals will have new titles and a new distribution schedule. Please provide proper attribution to the new journal names. On first reference, one time only, we would prefer that you provide this attribution:

"a study published online today in JAMA Neurology (formerly Archives of Neurology) ..."

The names are JAMA (specialty), not the Journal of the American Medical Association (specialty).

Here are the new titles and new embargo schedule:

Mondays 3pm central time/4pm eastern time
JAMA Pediatrics
JAMA Neurology
JAMA Internal Medicine

Embargoed content will be available on the For the Media site, http://media.jamanetwork.com on Thursdays

Wednesdays 3pm central time/4pm eastern time
JAMA Dermatology
JAMA Surgery
JAMA Psychiatry

Embargoed content will be available on the For the Media site on Mondays

Thursdays 3pm central time/4pm eastern time
JAMA Otolarynogology - Head & Neck Surgery
JAMA Ophthalmology
JAMA Facial Plastic Surgery

Embargoed content will be available on the For the Media site on Tuesdays

JAMA's embargo remains on Tuesdays at 3pm central time/4pm eastern time with embargoed content posted on the For the Media site on Thursdays. And, of course, we will continue to publish other articles Online First from all the journals with the occasional different embargo day and time.

We appreciate your attention to the new titles and schedule.
-end-


The JAMA Network Journals

Related Neurology Articles from Brightsurf:

Lancet Neurology publishes results of AFFiRiS' Phase 1 trial with PD01A in Parkinson's
AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced that detailed results of the phase 1 clinical program with its lead candidate PD01 in early Parkinson's disease (PD) patients were published in the peer-reviewed journal The Lancet Neurology

Telemedicine effective for monitoring patients in large pediatric neurology network
As the COVID-19 pandemic sent entire communities into lockdown, doctors quickly adopted telehealth strategies without knowing whether they would be effective or feasible.

The Lancet Neurology: Discovery could speed diagnosis and treatment of children with life-threatening neurological diseases
A group of life-threatening neurological conditions affecting children have been linked to an antibody which points to potential treatment, according to an observational multicentre study involving 535 children with central nervous system (CNS) demyelinating disorders and encephalitis, published in The Lancet Neurology journal.

Meaningful change in culture urged to save neurology, reduce gender gap
UC Davis School of Medicine dean, NINDS deputy director lead national charge to improve conditions for women in neurology.

BrainStorm Cell Tx publishes NurOwn ALS Phase 2 randomized trial data in neurology
Results from Brainstorm Cell Therapeutic's NurOwn randomized Phase 2 clinical trial were published in Neurology.

The Lancet Neurology: Pioneering study suggests that an exoskeleton for tetraplegia could be feasible
A whole-body exoskeleton, operated by recording and decoding brain signals, has helped a tetraplegic patient to move all four of his paralysed limbs, according to results of a 2-year trial published in The Lancet Neurology journal.

The Lancet Neurology: Frailty could make people more susceptible to dementia
New research published in The Lancet Neurology journal suggests that frailty makes older adults more susceptible to Alzheimer's dementia, and moderates the effects of dementia-related brain changes on dementia symptoms.

The Lancet Neurology: Cannabis-based drug in combination with other anti-spasticity
Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs.

New neurology studies a 'wakeup call' for global health
Neurology experts from around the world will convene Nov. 27 in New Zealand for a Global Brain Summit examining what one calls 'the greatest challenge of societies in the 21st century.' Among the neurological disorders to be discussed at the Summit are stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and migraine and other headaches.

The Lancet Neurology: Daily and weekly cycles of epileptic seizures more common than previously thought
Understanding the pattern of seizures, and how they are linked to circadian rhythms, could be important in improving management of epilepsy.

Read More: Neurology News and Neurology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.